Bakey while I tend to agree the short term valuations and comparisons here are fanciful, I'm sure you could perhaps relay your opinion in less condescending manner.
Also we are yet to hear what your thoughts are on the future share price, short, med, lon term.
Your hypothetical sounds good but you seem to miss the otherside. If PAA own the patents, and the shares are tightly held and if the technology works so well that companies want to acquire it....well then PAA sell for what they think is reasonable.
PHARMAUST ALL SET FOR ELY LILLY T/O, page-147
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |